2040, Cannabis and Extraction - Medical Cannabis Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2040

Cannabis

Extraction

Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.

Cannabinoids

Cannabinoids Pharmaceutical Treatment Patients

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods

Cannabis Law Report

JUNE 16, 2021

trillion meat market by 2040. AREV’s business model is driven by leveraging its core competency of extraction to produce ingredients and compounds for its pipeline of products. Bloomberg also projects that plant-based meat could make up a quarter of the USD $1.8

Food

Food Cultivation Agriculture Conditions

Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods

Stay Connected